These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Is there a role for monotherapy with beta-lactam antibiotics in the initial empirical management of febrile neutropenic cancer patients? Hathorn JW; Pizzo PA J Antimicrob Chemother; 1986 Mar; 17 Suppl A():41-54. PubMed ID: 3519563 [TBL] [Abstract][Full Text] [Related]
43. Role of glycopeptide antibiotics in the treatment of febrile neutropenic patients. Smith SR; Cheesbrough J; Harding I; Davies JM Br J Haematol; 1990 Dec; 76 Suppl 2():54-6. PubMed ID: 2149054 [TBL] [Abstract][Full Text] [Related]
44. Management in the febrile, neutropenic patient with cancer: therapeutic considerations. Brown AE J Pediatr; 1985 Jun; 106(6):1035-42. PubMed ID: 3889253 [TBL] [Abstract][Full Text] [Related]
45. Use of imipenem as empirical treatment of febrile neutropenia. Klastersky JA Int J Antimicrob Agents; 2003 May; 21(5):393-402. PubMed ID: 12727070 [TBL] [Abstract][Full Text] [Related]
46. A randomized case-controlled study of recombinant human granulocyte colony stimulating factor for the treatment of sepsis in preterm neutropenic infants. Aktaş D; Demirel B; Gürsoy T; Ovalı F Pediatr Neonatol; 2015 Jun; 56(3):171-5. PubMed ID: 25458637 [TBL] [Abstract][Full Text] [Related]
47. Imipenem/cilastatin versus piperacillin/tazobactam plus amikacin for empirical therapy in febrile neutropenic patients: results of the COSTINE study. Sanz MA; Bermúdez A; Rovira M; Besalduch J; Pascual MJ; Nocea G; Sanz-Rodríguez C; Curr Med Res Opin; 2005 May; 21(5):645-55. PubMed ID: 15969864 [TBL] [Abstract][Full Text] [Related]
48. Empirical antibiotic therapy in febrile neutropenic patients with single-daily dose amikacin plus ceftriaxone. Suwangool P; Aswapokee N; Sathapatayavongs B; Leelasuphasri S; Siritanaratkul N; Chuncharunee S; Chayakul P J Med Assoc Thai; 1993 Jun; 76(6):314-8. PubMed ID: 8083623 [TBL] [Abstract][Full Text] [Related]
49. The changing face of febrile neutropenia-from monotherapy to moulds to mucositis. Why empirical therapy? Klastersky J J Antimicrob Chemother; 2009 May; 63 Suppl 1():i14-5. PubMed ID: 19372173 [TBL] [Abstract][Full Text] [Related]
50. [Bacterial sepsis in the hematologic neutropenic patient]. Todeschini G; Benato G; Carlini S; Veneri D Haematologica; 1989 Oct; 74(5 Suppl):297-309. PubMed ID: 2480272 [No Abstract] [Full Text] [Related]
51. [Prevention and treatment of febrile neutropenia]. Montemurro F; Gallicchio M; Aglietta M Tumori; 1997; 83(2 Suppl):S15-9. PubMed ID: 9235724 [TBL] [Abstract][Full Text] [Related]
52. Efficacy of continuous infusion of ceftazidime for patients with neutropenic fever after high-dose chemotherapy and peripheral blood stem cell transplantation. Egerer G; Goldschmidt H; Salwender H; Hegenbart U; Ehrhard I; Haas R; Ho AD Int J Antimicrob Agents; 2000 Jul; 15(2):119-23. PubMed ID: 10854807 [TBL] [Abstract][Full Text] [Related]
53. Empirical antibiotics for febrile neutropenic cancer patients. Hathorn JW Eur J Cancer Clin Oncol; 1989; 25 Suppl 2():S43-51. PubMed ID: 2693109 [TBL] [Abstract][Full Text] [Related]